| Automatic tube type magnetic particle indirect chemiluminescence |
| 240T/h for single instrument,up to 960T/h for Four instruments online |
| Intra-batch repeatability, CV≤5% |
| Carry-over rate, ≤0.1ppm |
| 30 reagent positions, supporting multi-package combination |
| 240 sample positions, high-throughput injection system |
| Refrigerated reagent position, loading of reagent and consumables without shutdown |
| Three separate sample track design, surpport STAT use |
| High stability and low maintainability |

Accurate sample loading: Liquid level follow system, with the sample loading parameter of 10-200uL, meeting different sample requirements
Accurate temperature control: 37±0.2°C
Intra-batch repeatability: CV≤5%
Low carry-over rate : The needle tip is of conical structure, ≤0.1ppm (carry-over rate )
Fourth step cleaning: unique magnetic separation cleaning, ultra-low magnetic bead loss rate
High cup cleaning efficiency: Built-in sensor

Constant throughput: No deceleration for sample testing, throughput 240T/h, and up to 960T/h in 4 online instruments
Stability: Low fault rate and low maintenance cost

High sensitivity reaction system: ALP chemiluminescence reaction system, with advantages in small molecule test
High sensitivity substrate: Enhanced AMPPD chemiluminescence substrate with sensitivity up to 10-18 moL

User-friendly software: Easy to operate with a simple interface
Unique row cup system: Unattended for up to 6 hours when fully loaded
Priority for emergency treatment: Separate emergency channel
Intuitive and convenient consumable management: One-stop design, intelligent reminder

Automatic chemiluminescence immunoassay analyzer: CN202110661101.3
A gripper robot arm for automatic chemiluminescence immunoassay analyzer: CN202120717767.1
Automatic loading and dispatching mechanism of RV cuvette: CN202120721367.8
Calibration mechanism of a photomultiplier: CN202121642170.1
Enclosure of automatic chemiluminescence immunoassay analyzer: CN202130195641.8
Sample rack: CN202130448989.3
| Gastric | Thyroid | Tumor | Endocrine | Inflammation | Diabetes | Liver Fibrosis | |
| PGI | TSH | AFP | CEA | FSH | PCT | C-P | PIIINP |
| PGII | FT3 | CA125 | CA15-3 | PRL | IL-6 | INS | LN |
| G-17 | FT4 | tPSA | fPSA | LH | SAA | HA | |
| TT4 | CA72-4 | CA19-9 | P | CRP* | CIV | ||
| TT3 | CYFRA21-1 | SCC | T | CG | |||
| TG | NSE | HE4 | E2 | ||||
| Anti-TPO | Ferr | CA50 | β-HCG | ||||
| Anti-TG | CA242 | proGRP* | AMH | ||||
| TRAb* | β2-MG* | PIVKA-II** | SHBG* | ||||
| fE3* | |||||||
| F-hCGβ* | |||||||
| Infectious Diseases | Cardiac | Hypertension | Growth Hormone | Anemia | Bone metabolism |
| Pre S1** | CK-MB* | ALD** | IGF-I* | VB12* | iPTH* |
| HBeAg** | D-Dimer* | Cor** | hGH* | FA* | 25-OH-Vit-D* |
| HBsAg** | cTnT* | ACTH** | BGP* | ||
| HBeAb** | hs-cTnI* | DR** | CT* | ||
| HBsAb** | MYO* | Ang II** | |||
| HBcAb** | LP-PLA2* | ||||
| Anti-HCV** | BNP* | ||||
| HIV** | NT-proBNP* | ||||
| IGRA** | GAD65* | ||||
| Anti-TP** | H-FABP* | ||||
| HCY* |
Launched in December 2022 (*) under development (**)